MG(18:0/0:0/0:0)
|
Basic information |
| Metabolite name | MG(18:0/0:0/0:0) |
 | HMDB0011131 |
 |
C13856 |
 |
15560610 |
| Synonyms | 1-monostearin |
| No. of studies | 5 |
|
Basic information |
| Metabolite name | MG(18:0/0:0/0:0) |
| HMDB0011131 |
|
C13856 |
|
15560610 |
| Synonyms | 1-monostearin |
| No. of studies | 5 |
|
Relationship between MG(18:0/0:0/0:0) and depression (count: 5) |
| Study | Study Type  |
Comparison groups | Tissue | Organism | Up/Down regulated |
| Study M582 | Type1 | CUMS group vs. control group | Hippocampus | C57BL/6N mouse | Down |
| Study M582 | Type2 | CUMS + fluoxetine group vs. CUMS group | Hippocampus | C57BL/6N mouse | Up |
| Study M582 | Type3 | control + fluoxetine group vs. control group | Hippocampus | C57BL/6N mouse | Up |
| Study M685 | Type1 | SDS group vs. control group | Nucleus accumbens | C57BL/6J mouse | Up |
| Study M712 | Type1 | depression group vs. control group | Faece | Cynomolgus monkey | Down |
| Study M712 | Type1 | depression group vs. control group | Faece | Cynomolgus monkey | Up |
| Study M770 | Type4 | responder group vs. non-responder group | Serum | C57BL/6 mouse | Down |
| Study M869 | Type1 | CUMS group vs. control group | Peripheral blood mononuclear cell | Sprague-Dawley rat | Down |